One of the great challenges of modern day medical research is transferring fundamental biological discovery into societal benefit. This symposium draws together chemists, biologists and clinicians to discuss their own thoughts and approaches to delivering the “complete research pathway”.
Chair: Mike Malim, King's College London
14.00-14.10: Introduction and opening remarks
Jim Smith, MRC National Institute for Medical Research
14.10-14.40: The ups and downs of getting a new small molecule
therapy into the clinic
David Selwood, UCL
14.45-15.15: Type 1 diabetes: Is autoimmunity the problem or the solution?
Mark Peakman, King's College London
15.20-15.50: Validation of therapeutic targets for Huntington’s disease
Gill Bates, King's College London
15.50-16.20: Refreshment break
16.20-16.50: Using switchable mouse genetics to identify best
targets for cancer therapy
Gerard Evan, Cambridge University
16.55-17.25: Intratumour Heterogeneity: Evolution through Space and Time
Charlie Swanton, CR-UK London Research Institute
17.30-17.50: Closing comments
Richard Treisman, CR-UK London Research Institute
17:50 Drinks reception
Registration is essential. Please follow the instructions to register for the event.
For more information please visit: www.crick.ac.uk
When & Where
The Francis Crick Institute
The Francis Crick Institute will be a world-leading centre of biomedical research and innovation. It will promote connections between researchers, disciplines and academic institutions and between healthcare organisations and businesses. Dedicated to research excellence, the Institute will have the scale, vision and expertise to tackle the most challenging scientific questions underpinning health and disease.
Due to open in 2016, the Crick is a charity, supported by six of the world's most influential and respected scientific organisations: Cancer Research UK, the Medical Research Council, The Wellcome Trust, UCL (University College London), Imperial College London and King's College London.